Know Cancer

or
forgot password


N/A
N/A
N/A
Open (Enrolling)
Male
Prostatic Neoplasms, Genital Neoplasms, Male, Prostatic Diseases

Thank you

Trial Information


Inclusion Criteria:



- Patients suitable for surgery with confirmed prostate cancer, Gleason grade ≥ 3

- Patient has received no prior treatment for prostate cancer.

- Patient has adequate renal function: Estimated creatinine clearance ≥ 60 ml/minute.

- Patient must sign written informed consent according to the protocol approved by the
Regional Ethics Committee.

Exclusion Criteria:

- Patient with contraindication to MR or MR contrast media according to clinical
practice.

- Patients who want to withdraw for any reason during the study.

- Patients previously undergone pelvic surgery or radiation therapy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Authority:

Norway:National Committee for Medical and Health Research Ethics

Study ID:

REK-2010/1656

NCT ID:

NCT01464216

Start Date:

October 2011

Completion Date:

Related Keywords:

  • Prostatic Neoplasms
  • Genital Neoplasms, Male
  • Prostatic Diseases
  • Functional Magnetic Resonance Imaging
  • Prostate cancer
  • Neoplasms
  • Genital Neoplasms, Male
  • Prostatic Diseases
  • Prostatic Neoplasms

Name

Location